Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Cash: 2017-2024

Historic Change in Cash for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to -$72.6 million.

  • IDEAYA Biosciences' Change in Cash fell 15.17% to $184.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$101.5 million, marking a year-over-year decrease of 140.81%. This contributed to the annual value of -$72.6 million for FY2024, which is 181.53% down from last year.
  • IDEAYA Biosciences' Change in Cash amounted to -$72.6 million in FY2024, which was down 181.53% from $89.0 million recorded in FY2023.
  • IDEAYA Biosciences' Change in Cash's 5-year high stood at $89.0 million during FY2023, with a 5-year trough of -$72.6 million in FY2024.
  • For the 3-year period, IDEAYA Biosciences' Change in Cash averaged around -$2.3 million, with its median value being -$23.4 million (2022).
  • As far as peak fluctuations go, IDEAYA Biosciences' Change in Cash plummeted by 217.02% in 2022, and later surged by 480.27% in 2023.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' Change in Cash stood at $38.0 million in 2020, then crashed by 47.30% to $20.0 million in 2021, then crashed by 217.02% to -$23.4 million in 2022, then soared by 480.27% to $89.0 million in 2023, then tumbled by 181.53% to -$72.6 million in 2024.